RELIQ HEALTH TECHNOLOGIES IN (RHT.CA) Stock Income Statement
TSX-V:RHT - TSX Venture Exchange - CA75955T1030 - Common Stock - Currency: CAD
| TTM (2023-3-31) | 2022 (2022-6-30) | 2021 (2021-6-30) | 2020 (2020-6-30) | 2019 (2019-6-30) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 14.62M | 8.55M | 1.46M | 1.14M | 181.91K | |||
| Cost Of Goods | 5.76M | 3.25M | 604.21K | 968.67K | 174.07K | |||
| Gross Profit | 8.86M | 5.30M | 857.96K | 174.36K | 7.84K | |||
| Operating Expenses | 10.30M | 13.60M | 12.49M | 11.34M | 13.35M | |||
| Research and Development | 3.09M | 2.22M | 1.73M | 1.72M | 5.15M | |||
| Selling, General, and Administrative Expenses | 7.43M | 11.26M | 10.63M | 9.17M | 7.60M | |||
| Operating Income | -1.44M | -8.30M | -11.63M | -11.17M | -13.35M | |||
| Interest Income/Expense | 983.76K | 122.57K | -147.81K | -60.04K | -23.13K | |||
| Other Income/Expense | N/A | 2.19K | -5.64K | -58.35K | -34.41K | |||
| Non Recurring Items | N/A | N/A | N/A | 0.00 | 400.00K | |||
| Income Before Taxes | -457.61K | -8.17M | -11.78M | -11.12M | -13.00M | |||
| Net Income | -457.61K | -8.17M | -11.78M | -11.12M | -13.00M | |||
| EBITDA | -1.32M | -8.18M | -11.50M | -10.72M | -12.71M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.00 | -0.04 | -0.07 | -0.08 | -0.11 | |||
| Statistics | ||||||||
| Gross Profit Margin | 60.61% | 61.99% | 58.68% | 15.25% | 4.31% | |||
| Profit Margin | -3.13% | -95.55% | -805.69% | -973.06% | -7148.63% | |||
| Operating Profit Margin | -9.87% | -97.01% | -795.19% | -976.87% | -7336.89% | |||
All data in CAD